Pharmacoepigenetics in Type 2 Diabetes Mellitus
- 3 June 2019
- book chapter
- Published by Elsevier
- p. 563-571
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participantsThe Lancet, 2016
- The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled AnalysisPLOS ONE, 2013
- IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030Diabetes Research and Clinical Practice, 2011
- Type 2 Diabetes Can Be Prevented With Early Pharmacological InterventionDiabetes Care, 2011
- Economic Costs of Diabetes in the U.S. in 2007Diabetes Care, 2008
- Glycemic Durability of Rosiglitazone, Metformin, or Glyburide MonotherapyNew England Journal of Medicine, 2006
- Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessmentThe Lancet, 2006
- Rationale and options for combination therapy in the treatment of Type 2 diabetesDiabetologia, 2003
- Diabetes Mellitus: A Major Risk Factor for Cardiovascular DiseaseCirculation, 1999
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992